Lloyd S. Miller, MD, PhD, writes about understanding the overlapping immune pathways between psoriasis and psoriatic arthritis that may be useful to develop treatment plans for patients with these conditions.
John Botson, MD, provides his perspective on including immunodulatory therapy in combination with pegloticase and encourages clinicians to evolve their standard of care in the treatment of uncontrolled gout.
Jim Anderson, MPAS, PA-C, explores COVID-19 fatigue and how it is all a bit numbing for medical providers who are trying to do their best to treat patients while clinging to trusted sources to help guide the way.
Ben Nowell, PhD, and Shilpa Venkatachalam, PhD, provide an overview of the evolution of telemedicine during the COVID-19 pandemic and the associated barriers among patients with autoimmune rheumatic diseases.
Nicole Bundy, MD, discusses the ways in which health care professionals, including rheumatologists, can create meaningful relationships and have open communication with their patients with long-haul COVID.